Sepsis continues to be a major contributor to morbidity and mortality among hospitalized patients globally, especially within intensive care and emergency departments, where rapid recognition is essential for improving survival through timely treatment. In recent years, machine learning approaches have gained attention for their ability to predict sepsis onset using routinely collected electronic health record data. This systematic review, conducted in accordance with PRISMA 2020 guidelines, synthesizes evidence from studies published between 2017 and 2025, focusing on model architectures, feature selection and engineering strategies, prediction time horizons, and validation methodologies. Searches across major biomedical and informatics databases identified 67 eligible studies. The included literature shows that logistic regression, ensemble tree-based algorithms, and deep learning models are most frequently applied for sepsis prediction tasks. However, the majority of studies rely on retrospective datasets with internal validation, while only a limited number incorporate prospective or real-world validation frameworks. Overall, although reported model performance is often strong in retrospective analyses, a consistent decline in accuracy is observed when models are evaluated in real clinical environments. These findings highlight that prospective validation and improved generalizability are still underdeveloped areas, underscoring the need for future research to emphasize real-time deployment and robust external validation before clinical integration.
A small fraction of hospital episodes accounts for a disproportionate share of inpatient spending. Early recognition of these episodes remains difficult when risk assessment depends mainly on static admission information. More adaptive prediction is needed to support clinical and financial planning during hospitalization. Existing cost prediction models often emphasize claims, diagnoses, or broad utilization histories while underusing the dynamic signals that emerge during the inpatient stay. Pharmacy utilization, procedure sequencing, length-of-stay progression, and intensive care transfers may reveal escalating resource intensity before the final cost is known. Failure to integrate these modalities limits early identification of high-cost episodes. This article proposes a multimodal deep learning framework for predicting whether a hospitalization could become a high-cost outlier. The model is designed to combine pharmacy utilization, procedure sequences, length-of-stay trends, intensive care transfer events, and administrative claims data. The intended use is dynamic risk estimation early and repeatedly during the episode. The conceptual model uses separate modality-specific encoders for static claims features, temporal procedure events, pharmacy utilization patterns, length-of-stay trajectories, and intensive care transfer indicators. These representations are fused into a shared episode-level embedding trained with a cost-sensitive objective. The framework is intended for evaluation in historical and silent prospective deployment settings without assuming immediate clinical intervention effects. Conceptually, the model would output an updated probability that an active hospitalization will exceed a high-cost threshold. This probability would change as new medication orders, procedures, length-of-stay milestones, and intensive care transfers occur. The output could support utilization review, case management, pharmacy stewardship, and financial counseling workflows. A multimodal deep learning model for high-cost hospital episode prediction could help health systems identify emerging cost outliers before discharge. By combining static claims information with dynamic inpatient trajectories, such a model could support earlier resource allocation and more coordinated care planning. Its value should be assessed through careful validation, calibration, workflow integration, and prospective impact evaluation.